These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 19551697

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Psychiatric adverse drug reactions reported during a 10-year period in the Swedish pediatric population.
    Bygdell M, Brunlöf G, Wallerstedt SM, Kindblom JM.
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):79-86. PubMed ID: 22076661
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Analysis of behavior-related adverse experiences in clinical trials of montelukast.
    Philip G, Hustad CM, Malice MP, Noonan G, Ezekowitz A, Reiss TF, Knorr B.
    J Allergy Clin Immunol; 2009 Oct; 124(4):699-706.e8. PubMed ID: 19815116
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Psychiatric disorders associated with montelukast: data from the National Pharmacovigilance Database].
    Marchand MS, Jonville-Béra AP, Autret-Leca E, Association française des centres régionaux de pharmacovigilance.
    Arch Pediatr; 2013 Mar; 20(3):269-73. PubMed ID: 23375423
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
    Wahn U, Dass SB.
    Clin Ther; 2008 Mar; 30 Spec No():1026-35. PubMed ID: 18640477
    [Abstract] [Full Text] [Related]

  • 11. Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions.
    Bisgaard H, Skoner D, Boza ML, Tozzi CA, Newcomb K, Reiss TF, Knorr B, Noonan G.
    Pediatr Pulmonol; 2009 Jun; 44(6):568-79. PubMed ID: 19449366
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics and safety of montelukast oral granules in children 1 to 3 months of age with bronchiolitis.
    Kearns GL, Lu S, Maganti L, Li XS, Migoya E, Ahmed T, Knorr B, Reiss TF.
    J Clin Pharmacol; 2008 Apr; 48(4):502-11. PubMed ID: 18296556
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nightmares induced by montelukast in children and adults.
    Cereza G, Garcia Doladé N, Laporte JR.
    Eur Respir J; 2012 Dec; 40(6):1574-5. PubMed ID: 23204025
    [No Abstract] [Full Text] [Related]

  • 17. Nurses are increasingly involved in pharmacovigilance in Sweden.
    Ulfvarson J, Mejyr S, Bergman U.
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):532-7. PubMed ID: 17072915
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics and safety of montelukast in children aged 3 to 6 months.
    Knorr B, Maganti L, Ramakrishnan R, Tozzi CA, Migoya E, Kearns G.
    J Clin Pharmacol; 2006 Jun; 46(6):620-7. PubMed ID: 16707408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.